Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Healthcare Biotechnology
Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Man! Interest In This Stock Is Jumping!
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(99)
•••
Comment by Aarcoron Jul 16, 2021 12:00pm
147 Views
Post# 33559791

RE:RE:RE:RE:Man! Interest In This Stock Is Jumping!

RE:RE:RE:RE:Man! Interest In This Stock Is Jumping!It seems virtually none of the long term investors are actively investing via public markets in this stock.  That is a strong message to the CEO.

Chrispi and his crew back the company in financings.  They are happy with Rathjen because financings are risky but favorable, she keeps extending their warrants, and they are above water while retail holders are perpetually holding the big steaming bag.  Chrispi is highly motivated to promote the company, the CEO, and the BoD. That is all good.  I have no issues with any of that and understand where he/they are coming from.

From the other side of the fence, I see Rathjen and the BoD have promoted a pathetic business plan that relies on a 3rd party to dig the company out of the decade long hole it has been in.  While they may be esteemed in their healthcare profession, they are total failures as business people.  I would like to see them all resign today.  In the meantime, I'm holding several hundred thousand shares and riding the Chrispi Hope Train looking for a lottery ticket.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities